
Article 1 
The substance Salix spp. cortex as specified in Annex I is approved as basic substance subject to the conditions laid down in that Annex.
Article 2 
Part C of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
Article 3 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 8 July 2015.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX I

Common Name, Identification Numbers IUPAC Name Purity Date of approval Specific provisions
Salix spp. cortexCAS No: not allocatedCIPAC No: not allocated Not applicable European Pharmacopeia 1 July 2015 Salix cortex shall be used in accordance with the specific conditions included in the conclusions of the review report on Salix spp. cortex (SANCO/12173/2014) and in particular Appendices I and II thereof.

ANNEX II

In Part C of the Annex to Implementing Regulation (EC) No 540/2011, the following entry is added:

Number Common Name, Identification Numbers IUPAC Name Purity Date of approval Specific provisions
‘7 Salix spp. cortexCAS No: not allocatedCIPAC No: not allocated Not applicable European Pharmacopeia 1 July 2015 Salix cortex shall be used in accordance with the specific conditions included in the conclusions of the review report on Salix spp. cortex (SANCO/12173/2014) and in particular Appendices I and II thereof.’

